Assenagon Asset Management Portfolio holdings
AUM
$63B
This Quarter Return
+4.97%
1 Year Return
+16.23%
3 Year Return
+96.75%
5 Year Return
+146.12%
10 Year Return
–
AUM
$40.1B
AUM Growth
+$40.1B
(+6.5%)
Cap. Flow
+$3.05B
Cap. Flow
% of AUM
7.6%
Top 10 Holdings %
Top 10 Hldgs %
35.02%
Holding
1,475
New
160
Increased
556
Reduced
584
Closed
111
Top Buys
| 1 |
Apple
AAPL
|
$1.06B |
| 2 |
Costco
COST
|
$527M |
| 3 |
Starbucks
SBUX
|
$271M |
| 4 |
Sherwin-Williams
SHW
|
$268M |
| 5 |
Airbnb
ABNB
|
$255M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$1.25B |
| 2 |
Microsoft
MSFT
|
$903M |
| 3 |
NVIDIA
NVDA
|
$714M |
| 4 |
Applied Materials
AMAT
|
$376M |
| 5 |
Amazon
AMZN
|
$327M |
Sector Composition
| 1 | Technology | 32.05% |
| 2 | Consumer Discretionary | 16.7% |
| 3 | Healthcare | 13.58% |
| 4 | Financials | 9.25% |
| 5 | Communication Services | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Airgain
AIRG
$50.2M
| $89.3K | ﹤0.01% |
14,785
-365
| -2% | -$2.21K |
|
1352
Cato Corp
CATO
$83.2M
| $88K | ﹤0.01% |
+15,878
| New | +$88K |
|
|
SYRS
1353
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $81.9K | ﹤0.01% |
15,873
-154,126
| -91% | -$795K |
|
|
OPTN
1354
DELISTED
OptiNose
OPTN
| $79.2K | ﹤0.01% |
5,079
-727
| -13% | -$11.3K |
|
1355
Crawford & Co Class B
CRD.B
$523M
| $76.7K | ﹤0.01% |
+9,577
| New | +$76.7K |
|
1356
Culp
CULP
$52.7M
| $55.7K | ﹤0.01% |
12,440
+551
| +5% | +$2.47K |
|
1357
Oramed Pharmaceuticals
ORMP
$90.2M
| $42.2K | ﹤0.01% |
16,419
-2,240
| -12% | -$5.76K |
|
1358
Noodles & Co
NDLS
$31M
| $30.6K | ﹤0.01% |
+19,369
| New | +$30.6K |
|
|
1359
Crawford & Co Class A
CRD.A
$531M
| $29.2K | ﹤0.01% |
+3,379
| New | +$29.2K |
|
1360
Bolt Biotherapeutics
BOLT
$9.29M
| $25.9K | ﹤0.01% |
+1,724
| New | +$25.9K |
|
|
ENZ
1361
DELISTED
Enzo Biochem, Inc.
ENZ
| $21.6K | ﹤0.01% |
19,773
| – | – |
|
|
MAGN
1362
Magnera Corporation
MAGN
$413M
| $16K | ﹤0.01% |
883
-1,684
| -66% | -$30.4K |
|
|
TVRD
1363
Tvardi Therapeutics, Inc. Common Stock
TVRD
$270M
| $3.7K | ﹤0.01% |
399
-4,416
| -92% | -$41K |
|
1364
Ennis
EBF
$468M
| – | – |
-215,219
| Closed | -$4.41M |
|
1365
Applied Optoelectronics
AAOI
$1.44B
| – | – |
-631,799
| Closed | -$8.76M |
|
1366
Advance Auto Parts
AAP
$3.54B
| – | – |
-42,839
| Closed | -$3.65M |
|
1367
ACNB Corp
ACNB
$470M
| – | – |
-8,831
| Closed | -$332K |
|
1368
Adient
ADNT
$1.97B
| – | – |
-6,761
| Closed | -$223K |
|
1369
Adaptive Biotechnologies
ADPT
$1.96B
| – | – |
-844,852
| Closed | -$2.71M |
|
1370
Allete
ALE
$3.68B
| – | – |
-193,820
| Closed | -$11.6M |
|
1371
Amalgamated Financial
AMAL
$863M
| – | – |
-112,433
| Closed | -$2.7M |
|
1372
A.O. Smith
AOS
$9.92B
| – | – |
-118,823
| Closed | -$10.6M |
|
1373
Arcturus Therapeutics
ARCT
$467M
| – | – |
-55,237
| Closed | -$1.87M |
|
1374
argenx
ARGX
$44.2B
| – | – |
-7,287
| Closed | -$2.87M |
|
1375
Arlo Technologies
ARLO
$1.92B
| – | – |
-111,957
| Closed | -$1.42M |
|